Physician profile
Haley Miranda Simpson
NPI 1144782855
$4,246.88
in general payments reported to CMS, 2019-2025
6 companies · $4,227 in 2025
The $4,227 reported for 2025 was more than what 80% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $20.29 · 2025: $4,227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,321 · Food and Beverage: $926.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,320.95 |
| Food and Beverage | $925.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Legend Biotech USA INC. | $2,469.41 | 2025 | Carvykti |
| Janssen Biotech, INC. | $1,302.67 | 2025 | Talvey, Tecvayli, Carvykti |
| Astrazeneca Pharmaceuticals LP | $249.24 | 2025 | |
| Kite Pharma, INC. | $167.32 | 2025 | |
| Abbvie INC. | $55.07 | 2024-2025 | |
| Janssen Scientific Affairs, LLC | $3.17 | 2025 | Tecvayli, Carvykti, Talvey |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.